找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Open Source Knowledge Management; Georg Hüttenegger Book 2006 Springer-Verlag Berlin Heidelberg 2006 Content Management.Content Management

[复制链接]
楼主: Corrugate
发表于 2025-3-23 10:19:49 | 显示全部楼层
f 10 to 20% are not generally adequate to use as end points in phase 2 trials. In order to see reliable differences in survival in a phase 2 trial, a very striking treatment effect in a wellcontrolled setting is probably required. As a practical matter, to show benefit, most phase 3 studies of thera
发表于 2025-3-23 17:43:29 | 显示全部楼层
发表于 2025-3-23 21:58:32 | 显示全部楼层
me of the disease and the response to treatment. However, understanding the mechanisms used by tumor cells to evade the immune system could result in new therapeutic approaches for preventing and/or reversing these immune alterations and have the potential of improving the current results of immunotherapy trials.
发表于 2025-3-23 22:22:52 | 显示全部楼层
me of the disease and the response to treatment. However, understanding the mechanisms used by tumor cells to evade the immune system could result in new therapeutic approaches for preventing and/or reversing these immune alterations and have the potential of improving the current results of immunotherapy trials.
发表于 2025-3-24 04:54:26 | 显示全部楼层
dies or ligands that block negative signals (CTLA4) or provide costimulatory signals (4-1BB, OX40) will be extended or initiated soon. The next several years should prove particularly informative as trials incorporating combinations of strategies make their way to the clinic.
发表于 2025-3-24 09:47:04 | 显示全部楼层
h may contribute to inadequate phase 3 trials even when based on positive phase 2 data. However, even with well designed trials, rational vaccine development beyond the empiric evaluation of individual products will require a deeper understanding of human tumor immunobiology.
发表于 2025-3-24 11:57:18 | 显示全部楼层
发表于 2025-3-24 16:34:19 | 显示全部楼层
ll infiltration and tumor destruction by monitoring soluble factors and tumor growth. Human tumors engineered in 3D collagen scaffolds are excellent in vitro surrogates for avascular tumor stages allowing integrated analyses of the antitumor efficacy of cancer specific immunotherapy in situ.
发表于 2025-3-24 20:05:46 | 显示全部楼层
he beginning of the 20th century, vaccines for typhoid fever, rabies, polio, plaque and diphtherias were in use, and nowadays we are equipped with effectivevaccinesagainstmorethan20infectiousdiseasessuchasmeningitis,rubella, whooping cough, rabies, and hepat978-1-4419-5479-4978-0-387-27545-1Series ISSN 0927-3042 Series E-ISSN 2509-8497
发表于 2025-3-25 01:41:27 | 显示全部楼层
most aggressive malignant primary brain tumor in humans, glioblastoma multiforme. With comprehensive and cutting-edge information on therapeutic interventions and on the correct diagnosis of relevant neoplasms,978-94-024-0702-0978-94-007-5958-9
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-7 05:27
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表